BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26805963)

  • 1. Induction of protumoral CD11c(high) macrophages by glioma cancer stem cells through GM-CSF.
    Kokubu Y; Tabu K; Muramatsu N; Wang W; Murota Y; Nobuhisa I; Jinushi M; Taga T
    Genes Cells; 2016 Mar; 21(3):241-51. PubMed ID: 26805963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Synthetic Polymer Scaffold Reveals the Self-Maintenance Strategies of Rat Glioma Stem Cells by Organization of the Advantageous Niche.
    Tabu K; Muramatsu N; Mangani C; Wu M; Zhang R; Kimura T; Terashima K; Bizen N; Kimura R; Wang W; Murota Y; Kokubu Y; Nobuhisa I; Kagawa T; Kitabayashi I; Bradley M; Taga T
    Stem Cells; 2016 May; 34(5):1151-62. PubMed ID: 26822103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-Stimulated CAFs Enhance Monocyte Differentiation and Protumoral TAM Activation via IL6 and GM-CSF Secretion.
    Cho H; Seo Y; Loke KM; Kim SW; Oh SM; Kim JH; Soh J; Kim HS; Lee H; Kim J; Min JJ; Jung DW; Williams DR
    Clin Cancer Res; 2018 Nov; 24(21):5407-5421. PubMed ID: 29959142
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies.
    Sainz B; Carron E; Vallespinós M; Machado HL
    Mediators Inflamm; 2016; 2016():9012369. PubMed ID: 26980947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.
    Huang H; Wang C; Liu F; Li HZ; Peng G; Gao X; Dong KQ; Wang HR; Kong DP; Qu M; Dai LH; Wang KJ; Zhou Z; Yang J; Yang ZY; Cheng YQ; Tian QQ; Liu D; Xu CL; Xu DF; Cui XG; Sun YH
    Clin Cancer Res; 2018 Sep; 24(18):4612-4626. PubMed ID: 29691294
    [No Abstract]   [Full Text] [Related]  

  • 10. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.
    Lu H; Clauser KR; Tam WL; Fröse J; Ye X; Eaton EN; Reinhardt F; Donnenberg VS; Bhargava R; Carr SA; Weinberg RA
    Nat Cell Biol; 2014 Nov; 16(11):1105-17. PubMed ID: 25266422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
    Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target.
    Chen S; Zhao H; Deng J; Liao P; Xu Z; Cheng Y
    J Cell Biochem; 2013 Dec; 114(12):2795-808. PubMed ID: 23836528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-CSF expands dendritic cells and their progenitors in mouse liver.
    Pillarisetty VG; Miller G; Shah AB; DeMatteo RP
    Hepatology; 2003 Mar; 37(3):641-52. PubMed ID: 12601362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells are enriched in the side population cells in a mouse model of glioma.
    Harris MA; Yang H; Low BE; Mukherjee J; Guha A; Bronson RT; Shultz LD; Israel MA; Yun K
    Cancer Res; 2008 Dec; 68(24):10051-9. PubMed ID: 19074870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
    Pyonteck SM; Akkari L; Schuhmacher AJ; Bowman RL; Sevenich L; Quail DF; Olson OC; Quick ML; Huse JT; Teijeiro V; Setty M; Leslie CS; Oei Y; Pedraza A; Zhang J; Brennan CW; Sutton JC; Holland EC; Daniel D; Joyce JA
    Nat Med; 2013 Oct; 19(10):1264-72. PubMed ID: 24056773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors.
    Campisano S; Mac Keon S; Gazzaniga S; Ruiz MS; Traian MD; Mordoh J; Wainstok R
    Vaccine; 2013 Jan; 31(2):354-61. PubMed ID: 23146677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.
    Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Narita Y; Shibui S; Kayama T; Kitanaka C
    Stem Cell Res; 2014 Jan; 12(1):119-31. PubMed ID: 24185179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between M2 macrophages and glioma stem cells.
    Nusblat LM; Carroll MJ; Roth CM
    Cell Oncol (Dordr); 2017 Oct; 40(5):471-482. PubMed ID: 28643230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.